Pacira Pharmaceuticals (NSDQ:PCRX) said late last month that it plans to stop producing its liposomal chemotherapeutic due to “persistent technical issues specific to the DepoCyt(e) manufacturing process.” In a regulatory note filed to the SEC, the N.J.-based company said it expects a charge of $5 million thanks to the discontinuation, including $500,000 related to employee lay-offs. Get the […]
Oncology
MobileODT raises $7m for portable cervical cancer detection device
MobileODT said today that it raised $6.8 million in a Series B financing round. OrbiMed Advisors led the financing and was joined by a previous investor, Tristel. To date, the Israeli cancer diagnostic company has raised more than $13 million. MobileODT’s device, EVA, is a cheap, portable device that uses an imaging system to detect […]
Delcath raises $2m in Series B stock sale
Delcath Systems (NSDQ:DCTH) has raised $2 million after selling 2,360 shares of Series B preferred stock at $1,000 per share to unnamed institutional investors, according to a regulatory filing. The company wrote that it plans to use the proceeds for general corporate purposes. Get the full story at our sister site, Drug Delivery Business News.
Dune Medical raises $12m to expand MarginProbe footprint
Dune Medical Devices said today that it raised another $12 million it plans to use to expand the indications for the radiofrequency spectroscopy technology used in its MarginProbe cancer detection device. Alpharetta, Ga.- and Caesarea, Israel-based Dune said the $12.3 million round was led by Canepa Healthcare, ATON Partners and the Kraft Group. Dune said it plans […]
FDA requests more info on IsoRay’s GammaTile
IsoRay (NYSE:ISR) said today that the FDA requested additional data on the company’s pending 510(k) application for its GammaTile radiation therapy system. The Richland, Wash.-based company’s GammaTile is a radiation system using Cesium-131 radiation seeds embedded in a collagen ’tile’ which is designed to be placed in surgical margins at the time of surgery. “This is […]
FDA expands indication for DigniCap chemotherapy device
The FDA today cleared the expanded use of Dignitana‘s DigniCap Cooling System as a tool to reduce hair loss during chemotherapy. This marks the 1st time the U.S. regulatory agency has cleared a cooling cap for use in cancer patients with solid tumors, according to the FDA. Hair loss is common in patients taking certain […]
‘Nanolock’ could help diagnose and treat cancer with individualized therapies
In a study published in ACS Sensors, a team of researchers described how they develop a method to recognize a particular mutation in the genetic code of a cancerous cell. If cancers are caught early enough in the cell mutation process, many of them can be stopped with chemotherapy and other forms of treatment. This new […]
Varian Medical wins FDA nod for Halcyon radiotherapy cancer treatment system
Varian Medical (NYSE:VAR) said today it won FDA 510(k) clearance for its Halcyon image-guided volumetric intensity modulated radiotherapy cancer treatment system. The Palo Alto, Calif.-based company said its Halcyon IMRT system features improvements that make it more comfortable for patients and streamline operator’s workflow, only requiring 9 steps from start to treatment, down from 30 steps […]
7 medtech stories we missed this week: June 30, 2017
From ConforMIS touting its knee replacement study to Consulting Radiologists’s new breast cancer detection tool, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Study: Low-dose CT scanning improves Ankylosing Spondylitis assessment A new study has shown that low-dose computed tomography (LD-CT) is more sensitive than X-rays for monitoring […]
Augmenix debuts SpaceOar in Israel
Augmenix Inc. said this week that it launched its SpaceOar hydrogel device in Israel. The Bedford, Mass.-based company’s absorbable prostate-rectum spacer is designed to reduce rectal injury during prostate radiotherapy. Get the full story at our sister site, Drug Delivery Business News.
Could dogs be better than medical devices at detecting cancer?
Dogs in a small Japan town are being trained to detect stomach cancer through their scent to try to combat the high rates of stomach cancer in the area, according to media reports. The small 6,000-resident Japanese town of Kaneyama has high rates of stomach cancer and mayor Hiroshi Suzuki has taken to a sniffer […]